Tactical Allocation Channel4 ETFs to Consider with Big Pharma on the Senate’s Hot SeatBy Ben HernandezApril 9, 2019
Leveraged & Inverse ChannelBig Biopharma Mergers Could Fuel These ETFs in 2019By Ben HernandezJanuary 10, 2019
Leveraged & Inverse ChannelPharma Earnings: The PILL to CURE Market Troubles?By DirexionNovember 1, 2018
FeaturedDirexion Debuts Double Leveraged Cyber Security, Pharmaceuticals ETFsBy Tom LydonSeptember 16, 2015
